TY - JOUR
T1 - Neuromonitoring in neonatal critical care part I
T2 - neonatal encephalopathy and neonates with possible seizures
AU - El-Dib, Mohamed
AU - Abend, Nicholas S
AU - Austin, Topun
AU - Boylan, Geraldine
AU - Chock, Valerie
AU - Cilio, M Roberta
AU - Greisen, Gorm
AU - Hellström-Westas, Lena
AU - Lemmers, Petra
AU - Pellicer, Adelina
AU - Pressler, Ronit M
AU - Sansevere, Arnold
AU - Tsuchida, Tammy
AU - Vanhatalo, Sampsa
AU - Wusthoff, Courtney J
N1 - Funding Information:
M.E.-D. discloses he is the PI of an investigator-initiated research funded by Medtronic and served once on an advisory board for Radiometer. R.M.P. is an investigator for studies with UCB Biosciences, Inc and Johnson & Johnson and has served as a speaker, consultant and/or on advisory boards for Kephala, GW, Natus and UCB Biosciences, Inc. Her research is supported by the National Institute of Health Research (NIHR) Biomedical Research Centre at Great Ormand Street Hospital (GOSH), Cambridge Biomedical Research Centre NIHR and the Evelina Trust. Other authors are disclosing no financial interest.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
PY - 2023/7
Y1 - 2023/7
N2 - Abstract: The blooming of neonatal neurocritical care over the last decade reflects substantial advances in neuromonitoring and neuroprotection. The most commonly used brain monitoring tools in the neonatal intensive care unit (NICU) are amplitude integrated EEG (aEEG), full multichannel continuous EEG (cEEG), and near-infrared spectroscopy (NIRS). While some published guidelines address individual tools, there is no consensus on consistent, efficient, and beneficial use of these modalities in common NICU scenarios. This work reviews current evidence to assist decision making for best utilization of neuromonitoring modalities in neonates with encephalopathy or with possible seizures. Neuromonitoring approaches in extremely premature and critically ill neonates are discussed separately in the companion paper. Impact: Neuromonitoring techniques hold promise for improving neonatal care.For neonatal encephalopathy, aEEG can assist in screening for eligibility for therapeutic hypothermia, though should not be used to exclude otherwise eligible neonates. Continuous cEEG, aEEG and NIRS through rewarming can assist in prognostication.For neonates with possible seizures, cEEG is the gold standard for detection and diagnosis. If not available, aEEG as a screening tool is superior to clinical assessment alone. The use of seizure detection algorithms can help with timely seizures detection at the bedside.
AB - Abstract: The blooming of neonatal neurocritical care over the last decade reflects substantial advances in neuromonitoring and neuroprotection. The most commonly used brain monitoring tools in the neonatal intensive care unit (NICU) are amplitude integrated EEG (aEEG), full multichannel continuous EEG (cEEG), and near-infrared spectroscopy (NIRS). While some published guidelines address individual tools, there is no consensus on consistent, efficient, and beneficial use of these modalities in common NICU scenarios. This work reviews current evidence to assist decision making for best utilization of neuromonitoring modalities in neonates with encephalopathy or with possible seizures. Neuromonitoring approaches in extremely premature and critically ill neonates are discussed separately in the companion paper. Impact: Neuromonitoring techniques hold promise for improving neonatal care.For neonatal encephalopathy, aEEG can assist in screening for eligibility for therapeutic hypothermia, though should not be used to exclude otherwise eligible neonates. Continuous cEEG, aEEG and NIRS through rewarming can assist in prognostication.For neonates with possible seizures, cEEG is the gold standard for detection and diagnosis. If not available, aEEG as a screening tool is superior to clinical assessment alone. The use of seizure detection algorithms can help with timely seizures detection at the bedside.
UR - http://www.scopus.com/inward/record.url?scp=85143642942&partnerID=8YFLogxK
U2 - 10.1038/s41390-022-02393-1
DO - 10.1038/s41390-022-02393-1
M3 - Review article
C2 - 36476747
SN - 0031-3998
VL - 94
SP - 64
EP - 73
JO - Pediatric Research
JF - Pediatric Research
IS - 1
ER -